Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCORCencora
FinDog View：Neutral
TMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | COR | TMO |
|---|
| Close | 318.50 | 648.43 |
| Market Cap | $60.8B | $240B |
| 1M | +1.91% | +10.75% |
| P/E (TTM) | 23.5 | 34.4 |
| Forward P/E | 16.0 | 21.8 |
| P/E 5-Yr Percentile | 15 | 65 |
| P/S | 0.2 | 5.2 |
| P/B | 20.2 | 4.6 |
| Dividend Yield | 1.01% | 0.29% |
| Latest Quarter Revenue | $84.8B | $12.0B |
| Revenue YoY | +5.1% | +10.5% |
| Gross Margin | 4.3% | — |
| Latest Quarter EPS | 3.94 | 4.68 |
| Avg Post-Earnings Move | ±3.5% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 0.77% | 2.36% |
| 90-Day Net Insider Buying | −$2.7M | −$38.9M |
COR · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
